Conall H. Watson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Conall H. Watson has a total of 449 co-authors. Here are the top co-authors by number of shared publications:
- Eric James Nilles
Harvard Medical School
11 shared publications - Colleen L. Lau
The University of Queensland
10 shared publications Mike Kama
10 shared publicationsW John Edmunds
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom
10 shared publications- Alex James Elliot
Real-time Syndromic Surveillance Team, UK Health Security Agency, Birmingham, United Kingdom
7 shared publications - Daniel Todkill
UK Health Security Agency
7 shared publications
Latest Publications
- Open Access
- 10 September 2026
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 31 (36) , 2600752
Early impact of maternal RSV vaccination on bronchiolitis hospitalisation and critical care admissions in infants under age 3 months, England, September 2024 to March 2026
We conducted a time series analysis of hospitalisation and critical care admissions to evaluate the impact of maternal respiratory syncytial virus (RSV) vaccination in England from September 2024 to March 2026 in infants < 3 months of age. All bronchiolitis admissions decreased by 39.3% (IRR: 0.607, 95% CI: 0.576–0.640), and RSV bronchiolitis admissions by 62.6% (IRR: 0.374, 95% CI: 0.344–0.407). We estimated a 41.0% reduction in bronchiolitis critical care admissions (IRR: 0.590, 95% CI: 0.531–0.657). Maternal vaccine coverage was 55.1%. These findings support efforts to expand vaccine uptake.
- 10 September 2026
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 31 (36) , 2600752
Open AccessEarly impact of maternal RSV vaccination on bronchiolitis hospitalisation and critical care admissions in infants under age 3 months, England, September 2024 to March 2026
We conducted a time series analysis of hospitalisation and critical care admissions to evaluate the impact of maternal respiratory syncytial virus (RSV) vaccination in England from September 2024 to March 2026 in infants < 3 months of age. All bronchiolitis admissions decreased by 39.3% (IRR: 0.607, 95% CI: 0.576–0.640), and RSV bronchiolitis admissions by 62.6% (IRR: 0.374, 95% CI: 0.344–0.407). We estimated a 41.0% reduction in bronchiolitis critical care admissions (IRR: 0.590, 95% CI: 0.531–0.657). Maternal vaccine coverage was 55.1%. These findings support efforts to expand vaccine uptake.
- Open Access
Monitoring influenza-like symptoms in the UK through participatory surveillance: insights from FluSurvey over two winter seasons (2023-24 and 2024-25)
FluSurvey is a participatory surveillance system used to monitor trends in influenza and other respiratory viruses through weekly symptom surveys among the UK population. We aimed to characterise the wider impact of influenza-like illnesses (ILI) among FluSurvey participants and assess correlations of ILI with other established influenza surveillance systems. We included data reported by FluSurvey participants over the 2023-24 and 2024-25 winter seasons. Using weekly symptoms surveys, we derived ILI episodes and estimated the proportion reporting healthcare service use, medication use, impact on daily life, absenteeism and use of tests. We applied existing data methods (omitting first report and weighting to the age-sex structure of England) and assessed cross-correlations of weekly FluSurvey ILI rates with the national surveillance of GP ILI consultations, influenza hospital admissions, and influenza PCR test positivity at time lags of up to +/-2 weeks. There were 3057 participants over two winter seasons (N 2023-24 =2540, 63% female, mean age 60 years; N 2024-25 =2273, 64% female, mean age 61 years). Of 1868 ILI episodes, only a minority contacted healthcare services (14%, most frequently visiting the GP). A large proportion of episodes reported medication use (89%), impact on daily life (75%) and missing school or work (47%). Notable differences in testing behaviour were apparent by season, with fewer reporting use of tests in 2024-25. FluSurvey ILI rates were strongly correlated with other influenza surveillance, predominantly leading GP ILI consultations (max r=0.73), coinciding with influenza hospital admissions (max r=0.88) and lagging influenza test positivity (max r=0.88). The majority of ILI reported to FluSurvey do not contact healthcare due to symptoms but experienced wider impacts on daily life. FluSurvey ILI corresponds well with other national influenza surveillance and provides broader context on community illness, supplementing the monitoring of influenza activity for public health response.
Open AccessMonitoring influenza-like symptoms in the UK through participatory surveillance: insights from FluSurvey over two winter seasons (2023-24 and 2024-25)
FluSurvey is a participatory surveillance system used to monitor trends in influenza and other respiratory viruses through weekly symptom surveys among the UK population. We aimed to characterise the wider impact of influenza-like illnesses (ILI) among FluSurvey participants and assess correlations of ILI with other established influenza surveillance systems. We included data reported by FluSurvey participants over the 2023-24 and 2024-25 winter seasons. Using weekly symptoms surveys, we derived ILI episodes and estimated the proportion reporting healthcare service use, medication use, impact on daily life, absenteeism and use of tests. We applied existing data methods (omitting first report and weighting to the age-sex structure of England) and assessed cross-correlations of weekly FluSurvey ILI rates with the national surveillance of GP ILI consultations, influenza hospital admissions, and influenza PCR test positivity at time lags of up to +/-2 weeks. There were 3057 participants over two winter seasons (N 2023-24 =2540, 63% female, mean age 60 years; N 2024-25 =2273, 64% female, mean age 61 years). Of 1868 ILI episodes, only a minority contacted healthcare services (14%, most frequently visiting the GP). A large proportion of episodes reported medication use (89%), impact on daily life (75%) and missing school or work (47%). Notable differences in testing behaviour were apparent by season, with fewer reporting use of tests in 2024-25. FluSurvey ILI rates were strongly correlated with other influenza surveillance, predominantly leading GP ILI consultations (max r=0.73), coinciding with influenza hospital admissions (max r=0.88) and lagging influenza test positivity (max r=0.88). The majority of ILI reported to FluSurvey do not contact healthcare due to symptoms but experienced wider impacts on daily life. FluSurvey ILI corresponds well with other national influenza surveillance and provides broader context on community illness, supplementing the monitoring of influenza activity for public health response.
- Open Access
Healthcare-seeking behavior and hidden influenza-like-illness across the COVID-19 pandemic: a multi-country participatory surveillance study
Assessing healthcare seeking behavior is critical to estimate Influenza-like-illness (ILI) burden, i.e., the fraction of population infected, and inform vaccination campaigns for Influenza, SARS-CoV-2 and RSV, aimed at reducing disease circulation and severe illness. The Covid-19 pandemic put national healthcare systems under stress, affecting surveillance and healthcare seeking behavior of patients across demographic groups and countries. The under-reporting of influenza sentinel surveillance due to patients not consulting healthcare centers hinders consistent influenza burden estimates and hampers the understanding of influenza transmission at the international level. We leveraged an online participatory surveillance platform, InfluenzaNet, collecting data in six European countries, to study how the pandemic impacted individual healthcare seeking behavior in ILI patients and to estimate age-specific burden of ILI cases in terms of seasonal attack rates in the digital cohorts, hence including individuals who did not visit healthcare services. We studied drivers of healthcare seeking behavior such as demographics, socio-economic traits, comorbidities, duration and severity of symptoms, education and work status via a logistic regression model adjusted by age and sex of national populations, correcting for sampling biases. The presence of comorbidities, the duration and severity of the symptoms, and the self-assessed cause of symptoms, reflecting patients’ self-diagnosis, were drivers for health-seeking behavior consistently found across most countries, before and during the COVID-19 pandemic. The pandemic instead had a country-specific impact on age, gender, education and labor as determinants of healthcare seeking behavior throughout the crisis. We estimated ILI burden across countries using a standardized case definition, and assessed the burden of ILI that went undetected due to individuals not seeking healthcare from the general practitioner (GP, family physician) or other services. Our work highlights the advantage of integrating traditional systems with online participatory surveillance, which captures healthcare seeking behavior and helps to better assess the impact of pandemics on respiratory illnesses circulation. Further adoption of these tools has the potential to favor EU-level respiratory diseases surveillance, vaccination guidelines for Influenza, RSV and SARS-CoV-2 and a deeper understanding and management of ILI epidemiology and impact. Evidence before this study Before the SARS-CoV-2 pandemic, age, gender, education, the self-assessed cause of symptoms, their severity and duration were identified as known predictors of healthcare seeking behavior due to influenza-like-illness. However, most studies on population attendance to medical service focused on single countries, without assessing the robustness of these predictors across countries. Furthermore, it is not known what the impact of the pandemic was on their significance. Assessing healthcare seeking behavior is critical to estimate the burden of influenza-like-illness and inform decisions on the roll out of vaccination campaigns. We performed a literature search on Google Scholar using the keywords “ healthcare seeking behavior”, “ILI burden estimate”, “influenza-like-illness burden”, “burden estimate”, “ILI burden”, with no time limits, in the English language. Added value of this study Our study highlights the value of cross-country analyses by showing that not all known predictors of healthcare seeking behavior were robust across countries. Self-assessed cause of symptoms, their severity and duration proved robust across countries and pre-pandemic and pandemic periods except where small sample sizes prevented detection of significant effects. On the other hand, the pandemic had country-specific impact on socio-demographic predictors like age, gender, education and labor. Our work highlights substantial underdetection of ILI cases with respect to those estimated by national sentinel surveillance in all countries. Implications of all the available evidence This work suggests that the pandemic did not alter healthcare seeking behavior known predictors related to symptoms duration, severity and self-assessed cause, while we observed country-specific effects on age, gender and education factors. Digital cohorts may play a decisive role in integrating surveillance systems across countries for the estimation of ILI burden including medically unattended patients.
Open AccessHealthcare-seeking behavior and hidden influenza-like-illness across the COVID-19 pandemic: a multi-country participatory surveillance study
Assessing healthcare seeking behavior is critical to estimate Influenza-like-illness (ILI) burden, i.e., the fraction of population infected, and inform vaccination campaigns for Influenza, SARS-CoV-2 and RSV, aimed at reducing disease circulation and severe illness. The Covid-19 pandemic put national healthcare systems under stress, affecting surveillance and healthcare seeking behavior of patients across demographic groups and countries. The under-reporting of influenza sentinel surveillance due to patients not consulting healthcare centers hinders consistent influenza burden estimates and hampers the understanding of influenza transmission at the international level. We leveraged an online participatory surveillance platform, InfluenzaNet, collecting data in six European countries, to study how the pandemic impacted individual healthcare seeking behavior in ILI patients and to estimate age-specific burden of ILI cases in terms of seasonal attack rates in the digital cohorts, hence including individuals who did not visit healthcare services. We studied drivers of healthcare seeking behavior such as demographics, socio-economic traits, comorbidities, duration and severity of symptoms, education and work status via a logistic regression model adjusted by age and sex of national populations, correcting for sampling biases. The presence of comorbidities, the duration and severity of the symptoms, and the self-assessed cause of symptoms, reflecting patients’ self-diagnosis, were drivers for health-seeking behavior consistently found across most countries, before and during the COVID-19 pandemic. The pandemic instead had a country-specific impact on age, gender, education and labor as determinants of healthcare seeking behavior throughout the crisis. We estimated ILI burden across countries using a standardized case definition, and assessed the burden of ILI that went undetected due to individuals not seeking healthcare from the general practitioner (GP, family physician) or other services. Our work highlights the advantage of integrating traditional systems with online participatory surveillance, which captures healthcare seeking behavior and helps to better assess the impact of pandemics on respiratory illnesses circulation. Further adoption of these tools has the potential to favor EU-level respiratory diseases surveillance, vaccination guidelines for Influenza, RSV and SARS-CoV-2 and a deeper understanding and management of ILI epidemiology and impact. Evidence before this study Before the SARS-CoV-2 pandemic, age, gender, education, the self-assessed cause of symptoms, their severity and duration were identified as known predictors of healthcare seeking behavior due to influenza-like-illness. However, most studies on population attendance to medical service focused on single countries, without assessing the robustness of these predictors across countries. Furthermore, it is not known what the impact of the pandemic was on their significance. Assessing healthcare seeking behavior is critical to estimate the burden of influenza-like-illness and inform decisions on the roll out of vaccination campaigns. We performed a literature search on Google Scholar using the keywords “ healthcare seeking behavior”, “ILI burden estimate”, “influenza-like-illness burden”, “burden estimate”, “ILI burden”, with no time limits, in the English language. Added value of this study Our study highlights the value of cross-country analyses by showing that not all known predictors of healthcare seeking behavior were robust across countries. Self-assessed cause of symptoms, their severity and duration proved robust across countries and pre-pandemic and pandemic periods except where small sample sizes prevented detection of significant effects. On the other hand, the pandemic had country-specific impact on socio-demographic predictors like age, gender, education and labor. Our work highlights substantial underdetection of ILI cases with respect to those estimated by national sentinel surveillance in all countries. Implications of all the available evidence This work suggests that the pandemic did not alter healthcare seeking behavior known predictors related to symptoms duration, severity and self-assessed cause, while we observed country-specific effects on age, gender and education factors. Digital cohorts may play a decisive role in integrating surveillance systems across countries for the estimation of ILI burden including medically unattended patients.
- Open Access
Social behaviours and contact patterns across the 2020/21, 2021/22 and 2022/23 winter seasons in the UK, and associations with symptoms
The SARS-CoV-2 pandemic had a large impact on social mixing in the UK. This study analysed data from the Office for National Statistics Coronavirus Infection Survey to examine changes in contact patterns and self-reported symptoms through three winter seasons from 2020 to 2023. Using Generalised Additive Models, we estimated levels of various contacts over time, accounting for age, sex, ethnicity, and deprivation percentile, and compared these to trends in self-reported symptoms. Our estimates indicated steady increases in physical contacts from quarter-4 2020 to the end of the study in quarter-1 2023, with notable variation in age-specific trends. School closures and holiday periods had substantial impacts on contact patterns, particularly for children. Prevalence of reported symptoms also increased steadily over time, but varied much more within-season than most contacts; specifically, the relative increase in respiratory symptom prevalence during winter peaks between seasons was much larger than increases in contacts. Our estimates also suggested that while age played a crucial role in both contact patterns and symptom reporting, the effects of deprivation were less clear and far smaller. Our findings provide insights into changes in behaviours and symptoms during the pandemic, which may help inform future public health policy and infection modelling.
Open AccessSocial behaviours and contact patterns across the 2020/21, 2021/22 and 2022/23 winter seasons in the UK, and associations with symptoms
The SARS-CoV-2 pandemic had a large impact on social mixing in the UK. This study analysed data from the Office for National Statistics Coronavirus Infection Survey to examine changes in contact patterns and self-reported symptoms through three winter seasons from 2020 to 2023. Using Generalised Additive Models, we estimated levels of various contacts over time, accounting for age, sex, ethnicity, and deprivation percentile, and compared these to trends in self-reported symptoms. Our estimates indicated steady increases in physical contacts from quarter-4 2020 to the end of the study in quarter-1 2023, with notable variation in age-specific trends. School closures and holiday periods had substantial impacts on contact patterns, particularly for children. Prevalence of reported symptoms also increased steadily over time, but varied much more within-season than most contacts; specifically, the relative increase in respiratory symptom prevalence during winter peaks between seasons was much larger than increases in contacts. Our estimates also suggested that while age played a crucial role in both contact patterns and symptom reporting, the effects of deprivation were less clear and far smaller. Our findings provide insights into changes in behaviours and symptoms during the pandemic, which may help inform future public health policy and infection modelling.
- Open Access
Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospitalisation among adults aged 75-79 years in England
Background: A respiratory syncytial virus (RSV) vaccination programme for older adults using bivalent pre-F vaccine was introduced in England from September 1, 2024. While vaccine effectiveness has been reported against all-cause RSV-associated respiratory hospitalisations, there are limited data on vaccine effectiveness (VE) against different presentations of RSV-associated illness, such as exacerbation of chronic illness. Methods: We conducted a test-negative design analysis using data from a national, hospital-based acute respiratory infection (ARI) sentinel surveillance (HARISS) system across 14 hospitals in England. From October 1, 2024 to March 31, 2025 vaccine-eligible adults aged 75-79 years hospitalised with ARI for ≥24 hours and tested with molecular diagnostic assays within 48 hours of admission were included. Cases were RSV positive, and controls negative for RSV, influenza and SARS-CoV-2. Vaccination status was obtained from the national registry. Findings: Of 1006 adults hospitalised with ARI, 173 (17.2%) had RSV infection. VE was 82.3% (95%CI:70.6-90.0%) against hospitalisation for any RSV-associated ARI and 86.7% (75.4-93.6%) in those with severe disease including oxygen supplementation. VE was 88.6% (75.6-95.6%) among adults admitted due to lower respiratory tract infection (LRTI), including pneumonia, 77.4% (42.4-92.8%) among adults admitted due to exacerbation of chronic lung disease, and 78.8% (47.8-93.0%) among adults admitted with exacerbation of chronic heart disease, lung disease or frailty. In adults with immunosuppression, VE was 72.8% (39.5-89.3%). Interpretation: This study provides evidence that the RSV pre-F vaccine is highly effective against RSV-associated hospitalisations, including exacerbations of chronic disease and in adults living with immunosuppression. Funding: The UK Health Security Agency.
Open AccessVaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospitalisation among adults aged 75-79 years in England
Background: A respiratory syncytial virus (RSV) vaccination programme for older adults using bivalent pre-F vaccine was introduced in England from September 1, 2024. While vaccine effectiveness has been reported against all-cause RSV-associated respiratory hospitalisations, there are limited data on vaccine effectiveness (VE) against different presentations of RSV-associated illness, such as exacerbation of chronic illness. Methods: We conducted a test-negative design analysis using data from a national, hospital-based acute respiratory infection (ARI) sentinel surveillance (HARISS) system across 14 hospitals in England. From October 1, 2024 to March 31, 2025 vaccine-eligible adults aged 75-79 years hospitalised with ARI for ≥24 hours and tested with molecular diagnostic assays within 48 hours of admission were included. Cases were RSV positive, and controls negative for RSV, influenza and SARS-CoV-2. Vaccination status was obtained from the national registry. Findings: Of 1006 adults hospitalised with ARI, 173 (17.2%) had RSV infection. VE was 82.3% (95%CI:70.6-90.0%) against hospitalisation for any RSV-associated ARI and 86.7% (75.4-93.6%) in those with severe disease including oxygen supplementation. VE was 88.6% (75.6-95.6%) among adults admitted due to lower respiratory tract infection (LRTI), including pneumonia, 77.4% (42.4-92.8%) among adults admitted due to exacerbation of chronic lung disease, and 78.8% (47.8-93.0%) among adults admitted with exacerbation of chronic heart disease, lung disease or frailty. In adults with immunosuppression, VE was 72.8% (39.5-89.3%). Interpretation: This study provides evidence that the RSV pre-F vaccine is highly effective against RSV-associated hospitalisations, including exacerbations of chronic disease and in adults living with immunosuppression. Funding: The UK Health Security Agency.
- Open Access
- 31 May 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-7
Developing a syndromic surveillance tool to support the epidemiological investigation into paediatric acute hepatitis of unknown aetiology in England
Background: During 2022, a new public health threat emerged when cases of paediatric acute hepatitis of unknown aetiology (HUA) were identified in children aged under 16 years old in the United Kingdom (UK). At the time, the epidemiology and extent of cases was based upon limited and non-standardised reporting from hospitals and liver units. We aimed to adapt existing real-time syndromic surveillance systems to support the epidemiological investigation of cases of HUA presenting to emergency departments (EDs) in England. Methods: Syndromic surveillance is generally based on the collection of patient symptoms or chief complaints, which are collected using automated routines in near real-time. Here, we used an existing ED syndromic surveillance system monitoring daily patient attendances across a network of approximately 150 EDs in England. Clinical diagnosis codes related to the potential symptoms associated with the HUA incident were selected and attendance data monitored retrospectively and prospectively during the incident. Results: From 2 April 2018 to 31 December 2021, there were small sporadic numbers of daily ED attendances for ‘liver conditions’ in children with no observed secular trends or seasonality across the 1 to 4 and 5 to 14 years age groups. The period 2 April to 29 July was compared across each year included in the analysis. Mean daily HUA attendances during 2018 to 2021 was 0.05 and 0.22 for 1 to 4 and 5 to 14 years respectively, however in 2022 there were 0.26 and 0.42 mean daily attendances. This represented an increase of 377% and 94% in the 1 to 4 and 5 to 14 years age groups, respectively. From June 2022, daily syndromic ‘liver condition’ attendances appeared to decrease and the rate of increase in cumulative attendances slowed. Conclusions: We demonstrate how syndromic surveillance provided support to the HUA outbreak using an existing syndromic surveillance framework to develop new indicators based on the newly emerging clinical symptoms. The outputs from the syndromic tool matched clinical and epidemiological findings with respect to trends in other HUA-related data, including clinical and laboratory reports, over time. This work demonstrates the potential for syndromic surveillance supporting the epidemiological surveillance of hepatitis and providing a valuable tool for the real-time management of future unknown health threats.
- 31 May 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-7
Open AccessDeveloping a syndromic surveillance tool to support the epidemiological investigation into paediatric acute hepatitis of unknown aetiology in England
Background: During 2022, a new public health threat emerged when cases of paediatric acute hepatitis of unknown aetiology (HUA) were identified in children aged under 16 years old in the United Kingdom (UK). At the time, the epidemiology and extent of cases was based upon limited and non-standardised reporting from hospitals and liver units. We aimed to adapt existing real-time syndromic surveillance systems to support the epidemiological investigation of cases of HUA presenting to emergency departments (EDs) in England. Methods: Syndromic surveillance is generally based on the collection of patient symptoms or chief complaints, which are collected using automated routines in near real-time. Here, we used an existing ED syndromic surveillance system monitoring daily patient attendances across a network of approximately 150 EDs in England. Clinical diagnosis codes related to the potential symptoms associated with the HUA incident were selected and attendance data monitored retrospectively and prospectively during the incident. Results: From 2 April 2018 to 31 December 2021, there were small sporadic numbers of daily ED attendances for ‘liver conditions’ in children with no observed secular trends or seasonality across the 1 to 4 and 5 to 14 years age groups. The period 2 April to 29 July was compared across each year included in the analysis. Mean daily HUA attendances during 2018 to 2021 was 0.05 and 0.22 for 1 to 4 and 5 to 14 years respectively, however in 2022 there were 0.26 and 0.42 mean daily attendances. This represented an increase of 377% and 94% in the 1 to 4 and 5 to 14 years age groups, respectively. From June 2022, daily syndromic ‘liver condition’ attendances appeared to decrease and the rate of increase in cumulative attendances slowed. Conclusions: We demonstrate how syndromic surveillance provided support to the HUA outbreak using an existing syndromic surveillance framework to develop new indicators based on the newly emerging clinical symptoms. The outputs from the syndromic tool matched clinical and epidemiological findings with respect to trends in other HUA-related data, including clinical and laboratory reports, over time. This work demonstrates the potential for syndromic surveillance supporting the epidemiological surveillance of hepatitis and providing a valuable tool for the real-time management of future unknown health threats.
- Open Access
Influenza hospital admissions prevented by vaccination: a transmission dynamic analysis of the 2022/2023 and 2023/2024 programmes in England
We analyse the impact of the seasonal influenza vaccination programme over the 2022/2023 and 2023/2024 winter seasons in England, the first two full seasons since the re-emergence of influenza following the COVID-19 pandemic. Our approach adapts an existing age and risk-stratified SEEIIR dynamic transmission model, by additionally fitting to hospital admission surveillance data and allowing for changes in mixing patterns during school holiday periods. After forward modelling what would happen in counterfactual scenarios where all or various parts of the vaccination programme were removed, we find that vaccination greatly reduces the influenza-related healthcare burden in England, with an estimated 38,600 to 46,500 hospital admissions averted in 2022/2023 and 55,100 to 64,700 in 2023/2024. Across both seasons, we find that the school part of the programme prevented the most admissions, while in terms of the per-dose impact, the preschool and school parts of the programme were the most effective. Our study highlights vaccine effectiveness (VE) against infection and onwards transmission as a key data gap. In particular, we explore the possibility of lower VE against infection in a sensitivity analysis, and find that the number of averted admissions is reduced to 12,500 to 19,100 in 2022/2023 and 21,900 to 34,700 in 2023/2024.
Open AccessInfluenza hospital admissions prevented by vaccination: a transmission dynamic analysis of the 2022/2023 and 2023/2024 programmes in England
We analyse the impact of the seasonal influenza vaccination programme over the 2022/2023 and 2023/2024 winter seasons in England, the first two full seasons since the re-emergence of influenza following the COVID-19 pandemic. Our approach adapts an existing age and risk-stratified SEEIIR dynamic transmission model, by additionally fitting to hospital admission surveillance data and allowing for changes in mixing patterns during school holiday periods. After forward modelling what would happen in counterfactual scenarios where all or various parts of the vaccination programme were removed, we find that vaccination greatly reduces the influenza-related healthcare burden in England, with an estimated 38,600 to 46,500 hospital admissions averted in 2022/2023 and 55,100 to 64,700 in 2023/2024. Across both seasons, we find that the school part of the programme prevented the most admissions, while in terms of the per-dose impact, the preschool and school parts of the programme were the most effective. Our study highlights vaccine effectiveness (VE) against infection and onwards transmission as a key data gap. In particular, we explore the possibility of lower VE against infection in a sensitivity analysis, and find that the number of averted admissions is reduced to 12,500 to 19,100 in 2022/2023 and 21,900 to 34,700 in 2023/2024.
- Open Access
Estimating the disease burden of respiratory syncytial virus (RSV) in older adults in England during the 2023/24 season: a new national hospital-based surveillance system
Background Respiratory syncytial virus (RSV) is an important cause of acute respiratory infection (ARI) in older adults. Vaccines that protect against severe RSV infection are now available. Aim We aimed to describe the incidence, presentation, severity and clinical outcomes of RSV-associated ARI in hospitalised older adults using a new Hospital-based ARI Sentinel Surveillance (HARISS) system in England in the winter prior to RSV vaccine introduction. Methods Adults aged ≥65 years from seven hospitals admitted for ≥24 hours with symptomatic ARI were included. Three groups were identified: RSV positive; influenza positive; negative for RSV, influenza and SARS-CoV-2. We estimated the hospitalisation rate of RSV-associated ARI compared to influenza-associated ARI and assessed clinical outcomes using Poisson regression and mortality using Cox regression across groups. Results This surveillance study included 2743 adults. During the 2023/4 season the hospitalisation rate for RSV-associated ARI was 58.3 per 100,000, compared to 114.6 per 100,000 for influenza-associated ARI. Hospitalisation rates increased with age. Exacerbation of chronic illness including lung disease, heart disease or frailty was a frequent cause of admission in RSV-associated ARI, with a combined incidence of 33.1 per 100,000. The majority of adults with RSV-associated ARI had at least one comorbidity (81%); a high proportion with immunosuppression (26%). Symptoms and clinical outcomes including mortality were similar between RSV- and influenza-associated ARI; 30-day mortality 10.6% vs 8.7% (adjusted hazard ratio 0.85,95% confidence interval 0.6-1.2). Conclusion In England, RSV infection is a common cause of hospitalisation in older adults. Symptoms at presentation, severity and clinical outcomes, including mortality, are comparable to influenza.
Open AccessEstimating the disease burden of respiratory syncytial virus (RSV) in older adults in England during the 2023/24 season: a new national hospital-based surveillance system
Background Respiratory syncytial virus (RSV) is an important cause of acute respiratory infection (ARI) in older adults. Vaccines that protect against severe RSV infection are now available. Aim We aimed to describe the incidence, presentation, severity and clinical outcomes of RSV-associated ARI in hospitalised older adults using a new Hospital-based ARI Sentinel Surveillance (HARISS) system in England in the winter prior to RSV vaccine introduction. Methods Adults aged ≥65 years from seven hospitals admitted for ≥24 hours with symptomatic ARI were included. Three groups were identified: RSV positive; influenza positive; negative for RSV, influenza and SARS-CoV-2. We estimated the hospitalisation rate of RSV-associated ARI compared to influenza-associated ARI and assessed clinical outcomes using Poisson regression and mortality using Cox regression across groups. Results This surveillance study included 2743 adults. During the 2023/4 season the hospitalisation rate for RSV-associated ARI was 58.3 per 100,000, compared to 114.6 per 100,000 for influenza-associated ARI. Hospitalisation rates increased with age. Exacerbation of chronic illness including lung disease, heart disease or frailty was a frequent cause of admission in RSV-associated ARI, with a combined incidence of 33.1 per 100,000. The majority of adults with RSV-associated ARI had at least one comorbidity (81%); a high proportion with immunosuppression (26%). Symptoms and clinical outcomes including mortality were similar between RSV- and influenza-associated ARI; 30-day mortality 10.6% vs 8.7% (adjusted hazard ratio 0.85,95% confidence interval 0.6-1.2). Conclusion In England, RSV infection is a common cause of hospitalisation in older adults. Symptoms at presentation, severity and clinical outcomes, including mortality, are comparable to influenza.
- Open Access
Using machine learning to forecast peak health care service demand in real-time during the 2022-23 winter season: a pilot in England, UK
During winter months, there is increased pressure on health care systems in temperature climates due to seasonal increases in respiratory illnesses. Providing real-time short-term forecasts of the demand for health care services helps managers plan their services. During the Winter of 2022-23 we piloted a new forecasting pipeline, using existing surveillance indicators which are sensitive to increases in respiratory syncytial virus (RSV). Indicators including telehealth cough calls and ED bronchiolitis attendances, both in children under 5 years. We utilised machine learning techniques to train and select models that would best forecast the timing and intensity of peaks up to 28 days ahead. Forecast uncertainty was modelled usings a novel gamlss approach which enabled prediction intervals to vary according to the level of the forecast activity. The winter of 2022-23 was atypical because the demand for healthcare services in children was exceptionally high, due to RSV circulating in the community and increased concerns around invasive Group A streptococcal (GAS) infections. However, our short-term forecasts proved to be adaptive forecasting a new higher peak once the increasing demand due to GAS started. Thus, we have demonstrated the utility of our approach, adding forecasts to existing surveillance systems.
Open AccessUsing machine learning to forecast peak health care service demand in real-time during the 2022-23 winter season: a pilot in England, UK
During winter months, there is increased pressure on health care systems in temperature climates due to seasonal increases in respiratory illnesses. Providing real-time short-term forecasts of the demand for health care services helps managers plan their services. During the Winter of 2022-23 we piloted a new forecasting pipeline, using existing surveillance indicators which are sensitive to increases in respiratory syncytial virus (RSV). Indicators including telehealth cough calls and ED bronchiolitis attendances, both in children under 5 years. We utilised machine learning techniques to train and select models that would best forecast the timing and intensity of peaks up to 28 days ahead. Forecast uncertainty was modelled usings a novel gamlss approach which enabled prediction intervals to vary according to the level of the forecast activity. The winter of 2022-23 was atypical because the demand for healthcare services in children was exceptionally high, due to RSV circulating in the community and increased concerns around invasive Group A streptococcal (GAS) infections. However, our short-term forecasts proved to be adaptive forecasting a new higher peak once the increasing demand due to GAS started. Thus, we have demonstrated the utility of our approach, adding forecasts to existing surveillance systems.
- Open Access
- 29 August 2024
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 29 (35) , 2300682
Validation of an acute respiratory infection phenotyping algorithm to support robust computerised medical record-based respiratory sentinel surveillance, England, 2023
Introduction: Respiratory sentinel surveillance systems leveraging computerised medical records (CMR) use phenotyping algorithms to identify cases of interest, such as acute respiratory infection (ARI). The Oxford-Royal College of General Practitioners Research and Surveillance Centre (RSC) is the English primary care-based sentinel surveillance network. Aim: This study describes and validates the RSC’s new ARI phenotyping algorithm. Methods: We developed the phenotyping algorithm using a framework aligned with international interoperability standards. We validated our algorithm by comparing ARI events identified during the 2022/23 influenza season in England through use of both old and new algorithms. We compared clinical codes commonly used for recording ARI. Results: The new algorithm identified an additional 860,039 cases and excluded 52,258, resulting in a net increase of 807,781 cases (33.84%) of ARI compared to the old algorithm, with totals of 3,194,224 cases versus 2,386,443 cases. Of the 860,039 newly identified cases, the majority (63.7%) were due to identification of symptom codes suggestive of an ARI diagnosis not detected by the old algorithm. The 52,258 cases incorrectly identified by the old algorithm were due to inadvertent identification of chronic, recurrent, non-infectious and other non-ARI disease. Conclusion: We developed a new ARI phenotyping algorithm that more accurately identifies cases of ARI from the CMR. This will benefit public health by providing more accurate surveillance reports to public health authorities. This new algorithm can serve as a blueprint for other CMR-based surveillance systems wishing to develop similar phenotyping algorithms.
- 29 August 2024
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 29 (35) , 2300682
Open AccessValidation of an acute respiratory infection phenotyping algorithm to support robust computerised medical record-based respiratory sentinel surveillance, England, 2023
Introduction: Respiratory sentinel surveillance systems leveraging computerised medical records (CMR) use phenotyping algorithms to identify cases of interest, such as acute respiratory infection (ARI). The Oxford-Royal College of General Practitioners Research and Surveillance Centre (RSC) is the English primary care-based sentinel surveillance network. Aim: This study describes and validates the RSC’s new ARI phenotyping algorithm. Methods: We developed the phenotyping algorithm using a framework aligned with international interoperability standards. We validated our algorithm by comparing ARI events identified during the 2022/23 influenza season in England through use of both old and new algorithms. We compared clinical codes commonly used for recording ARI. Results: The new algorithm identified an additional 860,039 cases and excluded 52,258, resulting in a net increase of 807,781 cases (33.84%) of ARI compared to the old algorithm, with totals of 3,194,224 cases versus 2,386,443 cases. Of the 860,039 newly identified cases, the majority (63.7%) were due to identification of symptom codes suggestive of an ARI diagnosis not detected by the old algorithm. The 52,258 cases incorrectly identified by the old algorithm were due to inadvertent identification of chronic, recurrent, non-infectious and other non-ARI disease. Conclusion: We developed a new ARI phenotyping algorithm that more accurately identifies cases of ARI from the CMR. This will benefit public health by providing more accurate surveillance reports to public health authorities. This new algorithm can serve as a blueprint for other CMR-based surveillance systems wishing to develop similar phenotyping algorithms.